| Product Code: ETC12491724 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Netherlands continues to rely on imports of hydrochlorothiazide, with key suppliers in 2024 being China, India, Germany, UK, and Belgium. The market remains highly concentrated, with a high Herfindahl-Hirschman Index (HHI). However, there has been a significant decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -22.83%. Furthermore, the growth rate in 2024 experienced a sharp decline of -43.65%. These trends suggest a challenging market environment for hydrochlorothiazide imports in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Hydrochlorothiazide Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Hydrochlorothiazide Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Hydrochlorothiazide Market - Industry Life Cycle |
3.4 Netherlands Hydrochlorothiazide Market - Porter's Five Forces |
3.5 Netherlands Hydrochlorothiazide Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Hydrochlorothiazide Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Netherlands Hydrochlorothiazide Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Netherlands Hydrochlorothiazide Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Netherlands Hydrochlorothiazide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and related cardiovascular diseases |
4.2.2 Growing awareness about the importance of managing blood pressure |
4.2.3 Favorable government initiatives promoting healthcare access and affordability |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Presence of alternative medications for hypertension treatment |
4.3.3 Potential side effects and health risks associated with hydrochlorothiazide |
5 Netherlands Hydrochlorothiazide Market Trends |
6 Netherlands Hydrochlorothiazide Market, By Types |
6.1 Netherlands Hydrochlorothiazide Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Generic Hydrochlorothiazide, 2021 - 2031F |
6.1.4 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Branded Hydrochlorothiazide, 2021 - 2031F |
6.1.5 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.1.6 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Injectable Hydrochlorothiazide, 2021 - 2031F |
6.1.7 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Over-the-counter (OTC), 2021 - 2031F |
6.2 Netherlands Hydrochlorothiazide Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Tablet Formulation, 2021 - 2031F |
6.2.3 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Extended Release, 2021 - 2031F |
6.2.4 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Solubility Enhancement, 2021 - 2031F |
6.2.5 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Biopharmaceuticals, 2021 - 2031F |
6.2.6 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Nanotechnology, 2021 - 2031F |
6.3 Netherlands Hydrochlorothiazide Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.5 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.6 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Geriatric Patients, 2021 - 2031F |
6.4 Netherlands Hydrochlorothiazide Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Hypertension Treatment, 2021 - 2031F |
6.4.3 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Edema Management, 2021 - 2031F |
6.4.4 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Kidney Disorders, 2021 - 2031F |
6.4.5 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4.6 Netherlands Hydrochlorothiazide Market Revenues & Volume, By Water Retention, 2021 - 2031F |
7 Netherlands Hydrochlorothiazide Market Import-Export Trade Statistics |
7.1 Netherlands Hydrochlorothiazide Market Export to Major Countries |
7.2 Netherlands Hydrochlorothiazide Market Imports from Major Countries |
8 Netherlands Hydrochlorothiazide Market Key Performance Indicators |
8.1 Number of prescriptions for hydrochlorothiazide |
8.2 Patient adherence rates to hydrochlorothiazide treatment |
8.3 Number of healthcare providers recommending hydrochlorothiazide |
9 Netherlands Hydrochlorothiazide Market - Opportunity Assessment |
9.1 Netherlands Hydrochlorothiazide Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Hydrochlorothiazide Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 Netherlands Hydrochlorothiazide Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Netherlands Hydrochlorothiazide Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Netherlands Hydrochlorothiazide Market - Competitive Landscape |
10.1 Netherlands Hydrochlorothiazide Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Hydrochlorothiazide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here